Urotensin Related Peptides

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Online Inquiry

CAT# Product Name M.W Molecular Formula Inquiry
U03001 (Pyr-110)-Prepro-Urotensin II (110-123) (rat) 1663.90 C77H102N18O20S2 Inquiry
U03002 Urotensin II-Related Peptide (human, mouse, rat) C49H64N10O10S2 Inquiry
U03003 Urotensin II, human 1390.6 Inquiry
U03004 Urotensin II, rat, [pGlu110] - Prepro - Urotensin II (110 - 123), rat 1663.9 Inquiry
U03007 Urotensin II (Frog) 1517.76 C69H96N16O19S2, Inquiry
U03009 (Pyr1)-Urotensin II (rat) 1663.90 C₇₇H₁₀₂N₁₈O₂₀S₂ Inquiry
U03010 Orn8, Urotensin II, human 1374.6 C63H83N13O18S2 Inquiry
U03012 Urotensin II , goby 1361.57 C₆₂H₈₄N₁₄O₁₇S₂ Inquiry
U03014 Urotensin II-Related Peptide (human, mouse, rat) trifluoroacetate salt 1017.24 C₄₉H₆₄N₁₀O₁₀S₂ Inquiry

Urotensin-II (U-II) is the strongest vasopressin ligand known. Because the U-II system is involved in many biological systems, such as the cardiovascular system, nervous system, endocrine system, and kidney system, it is a promising target for the development of new drugs. Human Urotensin Ⅱ (hU-Ⅱ) is a polypeptide composed of 11 amino acids. The primary structure of Glu-Thr-Pro-Asp-cyclo [Cys-Phe-Trp-Lys-Tyr-Cys]-Val, is the strongest vasoconstrictor peptide known so far. Its C-terminal highly conserved hexapeptide structure Cys-Phe-Trp-Lys-Tyr-Cys is very similar to SST and OCT. U-II plays a vasoactive role by binding to its specific receptor GPR14. It has been found that SST and OCT can also compete to bind to the GPR14 receptor at high concentration and inhibit the vasoconstrictive activity of U-II.

Mode of Action

U-II plays a vasoactive role by binding to its specific orphan G-protein coupling receptor GPR-14. The vasoactive effect of U-II is race-specific and disease-specific. With the further study of U-II, it is found that U-II not only has vascular activity but also has the effect of promoting mitosis and fibrosis. It has been found that the expression of U-II is increased in plasma of patients with liver cirrhosis, but its role in the occurrence and development of chronic liver disease and portal hypertension. The mechanism is not yet clear.


U-II has different effects on different tissues. It can cause a contraction in blood vessels. In rat pancreas, U-II inhibits insulin secretion. It also affects the kidneys, including sodium transport, lipid, and glucose metabolism, and natriuretic action. It is associated with cardiac fibrosis and hypertrophy, heart failure, renal insufficiency, and diabetes. The increased expression of U-II and its receptor UT in the cirrhotic portal vein is closely related to the severity of the disease and complications such as ascetic fluid. However, the specific mechanism of U-II/UT system in the occurrence and development of cirrhotic portal vein disease is not clear. The application of U-II receptor antagonist can improve the hemodynamic disorder of portal hypertension and prevent hepatic fibrosis, suggesting that U-II receptor antagonist may be an important tool for the prevention and treatment of cirrhotic portal hypertension. The role in cirrhotic portal hypertension can provide a new idea for the treatment of cirrhotic portal hypertension.


  1. Merlino, F., Billard, É., Yousif, A. M., Di Maro, S., Brancaccio, D., Abate, L., ... & Marinelli, L. (2019). Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides. Journal of medicinal chemistry, 62(3), 1455-1467.
  2. Billard, É., Iddir, M., Nassour, H., Lee‐Gosselin, L., Poujol de Molliens, M., & Chatenet, D. (2019). New directions for urotensin II receptor ligands. Peptide Science, 111(1), e24056.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

An overview of trifluoroacetyl tripeptide-2  Peptides are chains of amino acids joined by peptide bond. Peptides are mostly i ...

 Gap 19 is a nonapeptide derived from the cytoplasmic loop (CL) of Connexin-43 (Cx43). Cx43 is a predominant card ...

Nociceptin/orphanin FQ (N/OFQ) modulates various biological functions, including nociception, via selective stim ...

 Urantide is a UⅡ receptor antagonist. It can effectively alleviate monocrotaline (MCT)-induced PAH in a rat mode ...

The mammalian precursor gene proglucagon, which contains the glucagon sequence together with two structurally related glucago ...

Quick Inquiry
Contact Us



Tel: |




Copyright © 2024 Creative Peptides. All rights reserved.